Results 241 to 250 of about 442,345 (289)

Prostate cancer - PI-RADS 5

, 2019
openaire   +1 more source

PI-RADS in Predicting csPCa: A Comparison Between Academic and Nonacademic Centers. [PDF]

Prostate
Orsini A, Ferretti S, Porreca A, Castellan P, Litterio G, Ciavarella D, De Palma A, Berardinelli F, Pizzi AD, D'Angelo E, di Nicola M, Schips L, Marchioni M.   +12 more
europepmc   +1 more source

Prostate nodule - PI-RADS 2

, 2018
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Head-to-head comparison of PI-RADS v2 and PI-RADS v1

European Journal of Radiology, 2016
To compare the reproducibility and diagnostic performance of PI-RADS version 2 (v2) and version 1 (v1) for the diagnosis of prostate cancer (PCa) on multiparametric MRI.This IRB-approved retrospective study included 65 consecutive biopsy-naïve or biopsy-negative patients suspicious for PCa (mean age: 65 years, mean PSA: 10.8ng/ml) who were undergoing ...
Stephan Polanec, Pascal Baltzer
exaly   +3 more sources

A Pictorial Review of PI-RADS v2.0 and PI-RADS v2.1: What Changed?

Contemporary Diagnostic Radiology, 2021
Prostate cancer (PCa) is the most common cancer among Canadian men (excluding nonmelanoma skin cancers) and is the third leading cause of death from cancer in men in Canada. It is estimated that, in 2020, 23,300 men will be diagnosed with PCa, representing 20% of all new cancer cases in men.1 The recommended technique being used for the detection and ...
Nicolas Gibson, Christopher Fung
openaire   +2 more sources

Perspectives and Concerns about PI-RADS and Variability

Radiology, 2021
Contains fulltext : 232925.pdf (Publisher’s version ) (Closed access)
Clare M. C. Tempany-Afdhal, Anwar Padhani, Jelle Barentsz, Jeffrey Weinreb   +3 more
openaire   +3 more sources

PI-RADS: Where Next?

Radiology, 2023
Prostate MRI plays an important role in the clinical management of localized prostate cancer, mainly assisting in biopsy decisions and guiding biopsy procedures. The Prostate Imaging Reporting and Data System (PI-RADS) has been available to radiologists since 2012, with the most up-to-date and actively used version being PI-RADS version 2.1.
Baris Turkbey, Andrei S. Purysko
openaire   +2 more sources

PI-RADS: multiparametric MRI in prostate cancer

Magnetic Resonance Materials in Physics, Biology and Medicine, 2022
Multiparametric MRI of the prostate gland has become the initial evaluation of biopsy naïve men with a clinical suspicion for prostate cancer. PI-RADS 2.1 is a joint initiative and framework for prostate MRI acquisition and reporting, which aims to standardize technique and interpretation across centers.
Aileen O’Shea, Mukesh Harisinghani
openaire   +2 more sources

PI‐RADS: Past, present, and future

Journal of Magnetic Resonance Imaging, 2019
Prostate cancer (PCa) is extremely prevalent and is the most common noncutaneous malignancy and second‐most common cause of cancer death in men. In the last decade, there has been dramatic growth in the use of multiparametric magnetic resonance imaging (mpMRI) for diagnosis and characterization of PCa.
Rajan T. Gupta, Kurren A. Mehta, Baris Turkbey, Sadhna Verma   +3 more
openaire   +2 more sources

Follow-up MR imaging of PI-RADS 3 and PI-RADS 4 prostate lesions

Clinical Imaging, 2017
To determine the rate of malignancy after follow-up MR imaging of the prostate in PI-RADS 3 lesions without core biopsy and PI-RADS 4 lesions after negative initial core biopsy.We performed follow-up MRI in 46/72 (64%) patients with PI-RADS 3 lesions and 26/72 (36%) patients with PI-RADS 4 lesions in baseline MRI.The rate of malignancy in PI-RADS 3 ...
Elke, Hauth, Horst, Jaeger, Horst, Hohmuth, Meinrad, Beer   +3 more
openaire   +2 more sources